Tech adopted during the pandemic looks set to continue as we transition into a world where the virus doesn’t control us. . . . → Read More: Tech Shaping the Post-Covid Healthcare Landscape
|
|||||
       |
National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of solid tumor cancer. . . . → Read More: NIH Funds Programmable mRNA to Treat Cancer  Comments are closed  Finance, New products  biomedical, biotechnology, cancer, entrepreneurs, genomics, grant, life sciences, NIH, pharmaceuticals, preclinical, university 
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator. . . . → Read More: Sanofi Acquires mRNA Developer in $3.2B Deal One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, clinical trials, Covid-19, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals 
A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases. . . . → Read More: Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, engineering, Europe, genomics, licensing, life sciences, nanotechnology, pharmaceuticals, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts